Pharmaceutical / Drug Definition :
Inhibits RNA synthesis by blocking RNA transcription in susceptible organisms (mycobacteria and some gram-positive and gram-negative bacteria
FDA Detentions
Rifapentine (Rifapentine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Rifapentine (Rifapentine Suppliers)
- Processors Rifapentine
- Repackers Rifapentine
- Relabelers Rifapentine
- Exporters Rifapentine
- Importers Rifapentine
For more information about Rifapentine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
